Shelia M. Violette - Oct 11, 2024 Form 4 Insider Report for Q32 Bio Inc. (QTTB)

Role
Chief Scientific Officer
Signature
/s/ Eric Bell, Attorney-in-Fact
Stock symbol
QTTB
Transactions as of
Oct 11, 2024
Transactions value $
$58,011
Form type
4
Date filed
10/16/2024, 08:39 PM
Previous filing
Oct 10, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction QTTB Common Stock Options Exercise $14.3K +4.57K +34.39% $3.12 17.9K Oct 11, 2024 Direct
transaction QTTB Common Stock Options Exercise $43.7K +6K +33.57% $7.29 23.9K Oct 15, 2024 Direct
holding QTTB Common Stock 36.3K Oct 11, 2024 By Violette Holdings LLC F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction QTTB Stock Option (Right to Buy) Options Exercise $0 -213 -100% $0.00 0 Oct 11, 2024 Common Stock 213 $3.12 Direct F2
transaction QTTB Stock Option (Right to Buy) Options Exercise $0 -4.36K -100% $0.00 0 Oct 11, 2024 Common Stock 4.36K $3.12 Direct F2
transaction QTTB Stock Option (Right to Buy) Options Exercise $0 -6K -15.43% $0.00 32.9K Oct 15, 2024 Common Stock 6K $7.29 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares held by Violette Holdings LLC ("Violette Holdings"). The Reporting Person is a manager of Violette Holdings and disclaims beneficial ownership of these shares except to the extent of her pecuniary interest therein, if any, and this report shall not be deemed an admission that she is the beneficial owner of such shares for purposes of Section 16 of the Exchange Act or for any other purpose.
F2 The shares underlying this option are fully vested and exercisable as of the date hereof.
F3 The shares underlying this option vest and become exercisable in sixteen (16) equal quarterly installments following December 2, 2020, subject to the Reporting Person's continued service on each such vesting date.